Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-21-013453

Options or other derivatives

  • Chief Executive Officer acquired 2,500,000 shares (grant or award)
  • Chief Executive Officer returned 1,500,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

KUMAR AMIT · Chief Executive Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-06-01 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +2,000,000 2,000,000 D
2021-06-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +500,000 500,000 D
2021-05-31 Returned to the company : show line 3 in the form Restricted Stock Award −1,500,000 0 D
Loading xslF345X03/ownership.xml…